Article info
PDFClinical ethics
Paper
Disclosure of incidental constituents of psychotherapy as a moral obligation for psychiatrists and psychotherapists
- Correspondence to Dr Manuel Trachsel, Institute of Biomedical Ethics, University of Zurich, Pestalozzistrasse 24, Zurich, Zurich 8032, Switzerland; manuel.trachsel{at}uzh.ch
Citation
Disclosure of incidental constituents of psychotherapy as a moral obligation for psychiatrists and psychotherapists
Publication history
- Received July 2, 2015
- Revised March 22, 2016
- Accepted April 18, 2016
- First published May 11, 2016.
Online issue publication
July 26, 2016
Article Versions
- Previous version (11 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Informed consent in neurosurgery—translating ethical theory into action
- Psychotherapy, placebos, and informed consent
- Medical ethics for children: applying the four principles to paediatrics
- Treating competent patients by force: the limits and lessons of Israel’s Patient’s Rights Act
- Talking more about talking cures: cognitive behavioural therapy and informed consent
- Towards evidence based bioethics
- Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection
- Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial
- HIV status: the prima facie right not to know the result
- Placebo effects and the molecular biological components involved